An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is crucial for the choice of proper treatment. Presently, precise recognition of these disorders relies on the combination of morphological, immunophenotypical, and cytogenetic/molecular features. The diagnostic workup in such situations implies the application of costly and time-consuming analyses, which are not always required, since an intensified treatment option is reasonably reserved to fit patients. The Italian Group of Haematopathology proposes herein a practical algorithm for the diagnosis of aggressive mature B cell lymphomas based on a stepwise approach, aimed to select cases deserving molecular analysis, in order to optimize time and res...
Distinguishing Burkitt lymphoma (BL) from B cell lymphoma, unclassifiable with features intermediate...
Distinguishing Burkitt lymphoma (BL) from B cell lymphoma, unclassifiable with features intermediate...
The entity 'B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
The generic term aggressive B-cell lymphoma includes a variety of entities, each with particular dia...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
The diffuse aggressive B-cell lymphomas, as recognised in the 2001 WHO classification, represent a c...
Background Aggressive mature B-cell non-Hodgkin's lymphomas (BCL) sharing features of Burkitt's lymp...
Objectives: Intermediate-to-large B-cell lymphomas represent a heterogeneous group of aggressive les...
Background: High-grade B-cell lymphoma (HGBL) with rearrangements of MYC and BCL2 and/or BCL6, calle...
Distinguishing Burkitt lymphoma (BL) from B cell lymphoma, unclassifiable with features intermediate...
Distinguishing Burkitt lymphoma (BL) from B cell lymphoma, unclassifiable with features intermediate...
The entity 'B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
The generic term aggressive B-cell lymphoma includes a variety of entities, each with particular dia...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
The diffuse aggressive B-cell lymphomas, as recognised in the 2001 WHO classification, represent a c...
Background Aggressive mature B-cell non-Hodgkin's lymphomas (BCL) sharing features of Burkitt's lymp...
Objectives: Intermediate-to-large B-cell lymphomas represent a heterogeneous group of aggressive les...
Background: High-grade B-cell lymphoma (HGBL) with rearrangements of MYC and BCL2 and/or BCL6, calle...
Distinguishing Burkitt lymphoma (BL) from B cell lymphoma, unclassifiable with features intermediate...
Distinguishing Burkitt lymphoma (BL) from B cell lymphoma, unclassifiable with features intermediate...
The entity 'B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell...